Frazier Life Sciences portfolio
18 tracked investments, 4 on the map, $1.3B raised across the mapped portfolio.
Frazier Life Sciences18 investments · 4 on the map · $1.3B raised- Krystal BiotechPost-IPO Equity
- Aspen NeuroscienceSeries C
- Alentis TherapeuticsSeries D
- AllakosPost-IPO Equity
Also in the portfolio
- Maze Therapeutics
- Angitia Biopharmaceuticals
- Enlaza Therapeutics
- GondolaBio
- Soleno Therapeutics
- Carmot Therapeutics
- Lassen Therapeutics
- Savara Pharmaceuticals
- Radionetics Oncology
- Eledon Pharmaceuticals
- Sidewinder Therapeutics
- Halda Therapeutics
- Callio Therapeutics
- iBio
Investors similar to Frazier Life Sciences
OrbiMed177 investments · 137 on the map · $9.6B raised
Braidwell19 investments · 6 on the map · $837.5M raised
New Enterprise Associates542 investments · 411 on the map · $13.4B raised
RA Capital Management150 investments · 92 on the map · $6.7B raised
Novo Holdings89 investments · 18 on the map · $4.9B raised
Redmile Group61 investments · 14 on the map · $5.4B raised